Dr. Richard Bartlett on Budesonide, the Silver Bullet COVID Treatment

Contact Your Elected Officials

Dr. Richard Bartlett talks about an effective treatment that is both intuitive and evidenced-based; a treatment easily positioned prehospital and rolled out into community settings.

He says, “I administer a common respiratory anti-inflammatory corticosteroid, Budesonide, via a nebulizer directly to the lungs at the first signs and symptoms of COVID-19 and concurrently initiate COVID-19 testing.”

Dear Senator Hall:

As a physician with frontline experience wrestling with COVID-19, I would like to share an effective treatment that is both intuitive and evidenced-based; a treatment easily positioned prehospital and rolled out into community settings. I discovered this treatment as a stopgap measure in order to empirically treat patients and manage their symptoms as the current recommendations from the CDC and WHO have no community-based strategies for COVID-19. To wit, the current guidelines only engage a course of treatment once symptoms have progressed to hospitalization and, in many occasions, an ICU admission with ventilator care. To explain this dilemma for Texans more clearly, the current guidelines discourage Texans from seeking any healthcare at all for mild to moderate symptoms; care only commences when Texansโ€™ symptoms are so severe they require critical care and hospitalization.

However, there is an easily deployable pre-hospital community-based treatment for Texans. I administer a common respiratory anti-inflammatory corticosteroid, Budesonide, via a nebulizer directly to the lungs at the first signs and symptoms of COVID-19 and concurrently initiate COVID-19 testing. My rationale for choosing Budesonide over other corticosteroids is that it appears to block most of the cytokine storm inflammatory chemicals that COVID-19 triggers. In addition to my discovery, other organizations and nations are reviewing inhaled Budesonide to treat COVID-19. Inhaled Budesonide is currently under study at the NIH and is also undergoing study in France. Spain and Oxford University have both, individually, announced plans to study inhaled Budesonide as a COVID-19 therapy.

Thus far, 100% of my patients appear to be symptom-free following a course of inhaled Budesonide therapy. These successful outcomes include Texans who are at the highest risk for a very poor prognosis. For example, an elderly woman who was my patient had two types of blood cancer and was immunocompromised and undergoing chemotherapy and radiation. She is now COVID-19 recovered with inhaled Budesonide therapy. (Note: To be COVID-19 recovered is defined as symptom-free with two consecutive negative tests.) Another one of my patients on the critical end of the spectrum included an elderly woman with a 50-year history of smoking, a history of high blood pressure and thyroid disease treatment, and a surgical history of four-vessel cardiac bypass surgery. Following a course of inhaled Budesonide therapy, she was also COVID-19 recovered. Both Texans avoided a hospitalization, a ventilator, and a possible demise.

Inhaled Budesonide is a therapy safe for fragile Texans. It has been studied and utilized for lung-related inflammation for over 20+ years and is safe enough for 2-pound infants in the NICU. As I reviewed the efficacy of corticosteroids in other COVID-19 settings, I found that many of the nations that initiated a variation of my treatment also found incredible success. For example, Taiwan, a nation of 24 million, treats early with a different inhaled corticosteroid and has had only had seven deaths over the duration of this pandemic. Or consider Japan, who also treated with an inhaled corticosteroid. Although Japanโ€™s demographics skew towards an older population, they have had only 977 deaths in a nation of 121 million. Likewise, consider South Korea with population of 50 million who recorded only 283 deaths using an inhaled corticosteroid. (see coronavirus.jhu.edu)

Finally, although the FDA does not have any approved medicines specifically for COVID19, they have approved Budesonide nebulizer therapy to treat other respiratory inflammatory disorders. As such, inhaled Budesonide is an intuitive frontline defense for the COVID-19 outbreak. And best of all, it is easily rolled-out in primary care delivery settings in Texas. Delayed treatment is not a valid health strategy for any disease including COVID-19. During my service on the Governor-appointed Health Disparities Taskforce for Texas, our recommendations always included access to early detection and treatment. It is my opinion that inhaled Budesonide therapy is one such early treatment for COVID-19.

Sincerely,
Richard P. Bartlett, MD

Case Study Report: SARS-CoV-2 and The Case for Empirical Treatment by Richard P. Bartlett, MD and Alexandria Watkins, DNP

ColumnByDrBartlettReCOVID-5

The Thinking Conservative
The Thinking Conservativehttps://www.thethinkingconservative.com/
The goal of THE THINKING CONSERVATIVE is to help us educate ourselves on conservative topics of importance to our freedom and our pursuit of happiness. We do this by sharing conservative opinions on all kinds of subjects, from all types of people, and all kinds of media, in a way that will challenge our perceptions and help us to make educated choices.

Why the Trump Administration is Sitting on the Epstein Files

President Trump, AG Bondi, and FBI Dir. Patel have the advantage over us in that they see the big overall picture when it comes to the Epstein List.

Trumpโ€™s โ€œMajor Statementโ€ On Russia Is A Clumsy Attempt To Thread The Needle

The โ€œmajor statementโ€ on Russia Trump hyped up turned out to be an attempt to thread the needle between escalating US involvement in Ukrainian and walking away from it.

AI Takes Customer Service from Doublespeak to Triplespeak

Corporations are replacing customer service agents with AI agents. Here's a real-life example of attempting to use AI to have my internet restored.

The Left’s Descent into Extremismย ย 

The political left, from mainstream Dems to radical Antifa, have embraced extremism, alienating swaths of the public and undermining their own influence.

Roger Stone Speaks About Trump at Turning Point USA

Longtime Donald Trump friend, Roger Stone, gave a speech at the 2025 TPUSA convention offering his take on the recent Epstein List controversy.

Border Czar Says Physical Appearance โ€˜Canโ€™t Be the Sole Reasonโ€™ to Detain Someone

Border czar Homan said comments were โ€œtaken out of contextโ€ and federal immigration enforcement agents can't detain people based on physical appearances alone.

Capacity of US Coal-Fired Power Plants to Fall Over 15 Percent by 2028

Total operating capacity of coal-fired power plants in US is set to drop to 145 GW by end of 2028, a 15% decline from the 172 GW in operation as of May.

Violence Against ICE Escalates Across America

ICE officers face increased confrontation on the street, which crosses the line between free speech and physical violence.

International Buyers Purchased $56 Billion Worth of US Homes in 1 Year

Foreign buyers purchased $56 billion worth of existing homes in the US between April 2024 and March 2025, up by 33.2% from the previous 12 months.

CMS Eyes 3.8 Percent Pay Hike for Doctors, Medicare Cost Cuts, and Chronic Care Expansion

Trump admin plan will save billions on wasteful spending, boost rates for doctors, and modernizing Medicare services, said HHS Sec. RFK, Jr.

DOGE Announces Billions of Dollars in Federal Contracts Terminated

In post on X on July 12, DOGE, stated that โ€œover the last week, agencies terminated 230 wasteful contracts,โ€ resulting in savings of $407 million.

Trump to Announce $70 Billion Energy and Innovation Investment in Pittsburgh

President Trump is meeting with business leaders to discuss how best to meet the energy and computing needs of the future.

Attorney General Pam Bondi Dismisses Justice Departmentโ€™s Top Ethics Lawyer

AG Pam Bondi terminated the head of the DOJโ€™s ethics division, according to a letter posted to social media by the fired official.
spot_img

Related Articles